Veterinary Medicines

Locatim inj.

Authorised
  • Immunoglobulins against Bovine coronavirus, Bovine
  • Immunoglobulins against Bovine rotavirus, Bovine
  • Immunoglobulins against Escherichia coli F5 antigen, Bovine
  • Immunoglobulins against Escherichia coli 078:80B, Bovine
  • BOVINE ROTAVIRUS IMMUNOGLOBULIN
Download as PDF

Product identification

Medicine name:
Locatim inj.
Active substance:
  • Immunoglobulins against Bovine coronavirus, Bovine
  • Immunoglobulins against Bovine rotavirus, Bovine
  • Immunoglobulins against Escherichia coli F5 antigen, Bovine
  • Immunoglobulins against Escherichia coli 078:80B, Bovine
  • BOVINE ROTAVIRUS IMMUNOGLOBULIN
Target species:
  • Cattle (pre-ruminant)
Route of administration:
  • Oral use
  • Subcutaneous use

Product details

Active substance and strength:
  • Immunoglobulins against Bovine coronavirus, Bovine
    0.00
    enzyme-linked immunosorbent assay unit
    /
    1.00
    millilitre(s)
  • Immunoglobulins against Bovine rotavirus, Bovine
    0.00
    enzyme-linked immunosorbent assay unit
    /
    1.00
    millilitre(s)
  • Immunoglobulins against Escherichia coli F5 antigen, Bovine
    0.00
    enzyme-linked immunosorbent assay unit
    /
    1.00
    millilitre(s)
  • Immunoglobulins against Escherichia coli 078:80B, Bovine
    0.01
    slow agglutination test unit(s)
    /
    1.00
    millilitre(s)
  • BOVINE ROTAVIRUS IMMUNOGLOBULIN
    100.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Oral use
    • Cattle (pre-ruminant)
      • Meat and offal
        0
        day
  • Subcutaneous use
    • Cattle (pre-ruminant)
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI02AM05
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Germany
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 18 of Regulation (EU) 2019/6)
Marketing authorisation holder:
  • Melchior Sante Animale
Marketing authorisation date:
Manufacturing sites for batch release:
  • Biokema Europe
Responsible authority:
  • Paul-Ehrlich-Institut
Authorisation number:
  • PEI.V.03587.01.1
Date of authorisation status change:

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 21/10/2025
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."